search

Inhibrx Biosciences, Inc. (INBX)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Bank of America Reveals 2.4% Ownership Stake in Inhibrx Biosciences
Oct 28, 2026

Bank of America Reveals 2.4% Ownership Stake in Inhibrx Biosciences

Bank of America Corp /DE/ has disclosed an amended Schedule 13G, reporting a beneficial ownership of 357,318 shares in Inhibrx Biosciences, Inc. as of September 30, 2026. This stake represents 2.4% of Inhibrx Biosciences' total outstanding shares and is held through various wholly-owned subsidiaries with shared voting and dispositive powers. The filing details the breakdown of shared authority among its subsidiaries like BofA Securities, Inc., Bank of America N.A., and Merrill Lynch International.
Company relevance
100.00%
Company sentiment
Somewhat-Bullish
Overall sentiment
Somewhat-Bullish